Jiho Han
Interventional Cardiology · New York, NYNPI 1053815407
Payments from drug & device makers
Across 147 payments — averaging $429.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$51K
- Medtronic$7K
- Abbott$2K
- Abiomed$900
- Boehringer Ingelheim$336
- AstraZeneca$268
- plus $2K from 23 others
What the payments were for
- Grants$57,00090%
- Travel & lodging$8151%
- Food & beverage$5,0298%
- Education$2670%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 7 | $50,524 |
| Medtronic | 6 | $7,340 |
| Abbott | 19 | $1,881 |
| Abiomed | 13 | $900 |
| Boehringer Ingelheim | 12 | $336 |
| AstraZeneca | 17 | $268 |
| Terumo Medical Corporation | 8 | $253 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $180 |
| Pfizer | 12 | $165 |
| Novartis | 6 | $157 |
| Cvrx, Inc. | 1 | $135 |
| Lantheus Medical Imaging, Inc. | 6 | $114 |
| Amgen | 1 | $107 |
| Johnson & Johnson | 7 | $104 |
| Edwards Lifesciences | 3 | $89 |
| Acist Medical Systems, Inc. | 3 | $84 |
| Philips North America LLC | 1 | $71 |
| Alnylam Pharmaceuticals Inc. | 2 | $67 |
| Asahi Intecc USA, Inc. | 1 | $60 |
| Merck | 3 | $47 |
| Cardiva Medical, Inc. | 3 | $44 |
| Angiodynamics, Inc. | 1 | $41 |
| E.r. Squibb & Sons, L.L.C. | 2 | $34 |
| Cordis US CORP. | 1 | $24 |
| Scpharmaceuticals Inc. | 1 | $24 |
| Heartflow, Inc. | 1 | $17 |
| Lexicon Pharmaceuticals, Inc. | 1 | $17 |
| ZOLL Circulation Inc | 1 | $15 |
| Livanova USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL ATHERECTOMY$50,000
- OPTIS$754
- Impella$289
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$282
- CLINICAL TRIAL PRODUCT$165
- ONYX FRONTIER$164
- AVVIGO Guidance System$156
- Barostim Neo System$135
- GENERAL VASCULAR ACCESS$123
- JARDIANCE$116
- METACROSS OTW$111
- TR Band$111
- Heartrail$111
- ANGIO-SEAL$111
- Repatha$107
- ENSITE$103
How this compares
$63,111 in reported general payments places this provider in the 75th percentile of 382 interventional cardiology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 12 | $13,013 |
| FarxigaDapagliflozin Propanediol | 11 | $9,934 |
| Metoprolol Succinate | 22 | $391 |
| Rosuvastatin Calcium | 15 | $248 |
| Atorvastatin Calcium | 25 | $151 |
| Spironolactone | 22 | $117 |
| Amlodipine Besylate | 17 | $101 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $157 | $13,01312 claims |
| AstraZenecaFarxiga | $268 | $9,93411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 382 interventional cardiology providers in New York.
Other interventional cardiology in New York
- Martin LeonNew York$13.5M
- Susheel KodaliNew York$6M
- Deepak BhattNew York$4.1M
- Samin SharmaNew York$3.7M
- Annapoorna KiniNew York$3.5M
- Sahil ParikhNew York$2.7M
- George DangasNew York$2.6M
- Prakash KrishnanNew York$2M
- Ajay KirtaneNew York$1.8M
- Shing-Chiu WongNew York$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.